(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.78%) $83.20
(1.25%) $1.947
(-0.23%) $2 341.70
(0.20%) $27.59
(0.73%) $928.80
(-0.26%) $0.932
(-0.29%) $10.99
(-0.35%) $0.798
(0.25%) $92.11
4.55% HKD 36.80
Live Chart Being Loaded With Signals
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally...
Stats | |
---|---|
Tagesvolumen | 7.26M |
Durchschnittsvolumen | 10.39M |
Marktkapitalisierung | 135.91B |
EPS | HKD0.940 ( 2023-10-31 ) |
Last Dividend | HKD0.989 ( 2023-06-05 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.51 |
ATR14 | HKD0.0670 (0.18%) |
Volumen Korrelation
WuXi AppTec Co., Ltd. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
WuXi AppTec Co., Ltd. Korrelation - Währung/Rohstoff
WuXi AppTec Co., Ltd. Finanzdaten
Annual | 2023 |
Umsatz: | HKD40.34B |
Bruttogewinn: | HKD16.61B (41.18 %) |
EPS: | HKD3.27 |
FY | 2023 |
Umsatz: | HKD40.34B |
Bruttogewinn: | HKD16.61B (41.18 %) |
EPS: | HKD3.27 |
FY | 2022 |
Umsatz: | HKD39.35B |
Bruttogewinn: | HKD14.68B (37.30 %) |
EPS: | HKD3.15 |
FY | 2021 |
Umsatz: | HKD22.90B |
Bruttogewinn: | HKD8.31B (36.28 %) |
EPS: | HKD1.820 |
Financial Reports:
No articles found.
WuXi AppTec Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.989 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.281 | 2019-06-17 |
Last Dividend | HKD0.989 | 2023-06-05 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD2.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.38 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3939.HK | Ex Dividend Junior | 2023-06-07 | Annually | 0 | 0.00% | |
1776.HK | Ex Dividend Junior | 2023-07-11 | Annually | 0 | 0.00% | |
0817.HK | Ex Dividend Junior | 2023-09-18 | Semi-Annually | 0 | 0.00% | |
2359.HK | Ex Dividend Knight | 2023-06-05 | Annually | 0 | 0.00% | |
1345.HK | Ex Dividend Junior | 2023-10-04 | Semi-Annually | 0 | 0.00% | |
0390.HK | Ex Dividend Junior | 2023-07-19 | Annually | 0 | 0.00% | |
6626.HK | Ex Dividend Knight | 2023-09-04 | Annually | 0 | 0.00% | |
1897.HK | Ex Dividend Knight | 2023-07-05 | Semi-Annually | 0 | 0.00% | |
0921.HK | Ex Dividend Junior | 2023-07-10 | Sporadic | 0 | 0.00% | |
0052.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.238 | 1.500 | 5.24 | 7.86 | [0 - 0.5] |
returnOnAssetsTTM | 0.130 | 1.200 | 5.65 | 6.78 | [0 - 0.3] |
returnOnEquityTTM | 0.187 | 1.500 | 9.04 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.287 | -1.000 | 7.13 | -7.13 | [0 - 1] |
currentRatioTTM | 2.06 | 0.800 | 4.69 | 3.75 | [1 - 3] |
quickRatioTTM | 1.610 | 0.800 | 5.24 | 4.19 | [0.8 - 2.5] |
cashRatioTTM | 0.933 | 1.500 | 5.93 | 8.89 | [0.2 - 2] |
debtRatioTTM | 0.0780 | -1.500 | 8.70 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 61.33 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.35 | 2.00 | 8.83 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.104 | -1.500 | 9.58 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.47 | 6.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.294 | 1.000 | 6.11 | 6.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.18 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.548 | 0.800 | 9.68 | 7.75 | [0.5 - 2] |
Total Score | 12.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.12 | 1.000 | 9.08 | 0 | [1 - 100] |
returnOnEquityTTM | 0.187 | 2.50 | 9.38 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.35 | 2.00 | 9.22 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.04 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.287 | 1.500 | 7.13 | -7.13 | [0 - 1] |
pegRatioTTM | 0.503 | 1.500 | 9.98 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.311 | 1.000 | 4.74 | 0 | [0.1 - 0.5] |
Total Score | 7.38 |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.